Lantheus Holdings, Inc.

NASDAQ:LNTH

53.63 (USD) • At close September 8, 2025
Bedrijfsnaam Lantheus Holdings, Inc.
Symbool LNTH
Munteenheid USD
Prijs 53.63
Beurswaarde 3,646,528,946
Dividendpercentage 0%
52-weken bereik 47.25 - 118.21
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Ms. Mary Anne Heino
Website https://www.lantheus.com

An error occurred while fetching data.

Over Lantheus Holdings, Inc.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to

Vergelijkbare Aandelen

Premier, Inc. logo

Premier, Inc.

PINC

27.11 USD

Medpace Holdings, Inc. logo

Medpace Holdings, Inc.

MEDP

492.09 USD

The Ensign Group, Inc. logo

The Ensign Group, Inc.

ENSG

174.12 USD

Apellis Pharmaceuticals, Inc. logo

Apellis Pharmaceuticals, Inc.

APLS

26.91 USD

Tandem Diabetes Care, Inc. logo

Tandem Diabetes Care, Inc.

TNDM

12.5 USD

ICU Medical, Inc. logo

ICU Medical, Inc.

ICUI

130.58 USD

Alkermes plc logo

Alkermes plc

ALKS

28.45 USD

Evotec SE logo

Evotec SE

EVO

8.69 USD

QuidelOrtho Corporation logo

QuidelOrtho Corporation

QDEL

28.47 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)